Synthesis of Fluorescent 1-(3-Amino-4-(4-(tert-butyl)phenyl)−6-(p-tolyl)furo[2,3-b]pyridin-2-yl)ethan-1-one: Crystal Structure, Fluorescence Behavior, Antimicrobial and Antioxidant Studies

被引:0
|
作者
Mohammad M. Ibrahim
Mahmoud Al-Refai
Abdullah Al-Fawwaz
Basem F. Ali
Armin Geyer
Klaus Harms
Michael Marsch
Michelle Krüger
Hasnah Osman
Mohamad N. Azmi
机构
[1] Al al-Bayt University,Department of Chemistry, Faculty of Science
[2] Al al-Bayt University,Department of Biological Sciences, Faculty of Science
[3] King Faisal University,Department of Chemistry
[4] Philipps University Marburg,Faculty of Chemistry
[5] Universiti Sains Malaysia,School of Chemical Sciences
来源
Journal of Fluorescence | 2018年 / 28卷
关键词
Furo[2,3-; ]pyridine; Antioxidant activity; Crystal structure; Fluorescence;
D O I
暂无
中图分类号
学科分类号
摘要
Furopyridine III, namely 1-(3-amino-4-(4-(tert-butyl)phenyl)-6-(p-tolyl)furo[2,3-b]pyridin-2-yl)ethan-1-one, synthesized from 4-(4-(tert-butyl)phenyl)-2-oxo-6-(p-tolyl)-1,2-dihydropyridine-3-carbonitrile I in two steps. The title compound is characterized by NMR, MS and its X-ray structure. The molecular structure consists of planar furopyridine ring with both phenyl rings being inclined from the furopyridine scaffold to a significant different extent. There are three intramolecular hydrogen bonds within the structure. The lattice is stabilized by N—H…O, H2C—H …π and π…π intermolecular interactions leading to three-dimensional network. Compound III exhibits fluorescent properties, which are investigated. Antimicrobial potential and antioxidant activity screening studies for the title compound III and the heterocyclic derivatives, I and II, show no activity towards neither bacterial nor fungal strains, while they exhibited weak to moderate antioxidant activity compared to reference.
引用
收藏
页码:655 / 662
页数:7
相关论文
共 50 条
  • [41] Crystal structure of 4-(4-((3-bromophenyl)amino)-6-(tert-butyl)-3-(2-hydroxypropan-2-yl)cinnolin-8-yl)-2-methylbut-3-yn-2-ol, C26H30BrN3O2
    Yuan, Yue-Hua
    Yin, Qiang-Feng
    Tian, Mao-Zhong
    Feng, Feng
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (04): : 1211 - 1213
  • [42] Synthesis and preliminary evaluation of 18F-labeled 1-(6,7-dimethyl-4-(methylamino)-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-2-(trans-2-(6-fluoropyridin-3-yl)cyclopropyl)ethan-1-one for imaging muscarinic acetylcholine receptor subtype 4
    Deng, Xiaoyun
    Zhang, Yiding
    Rong, Jian
    Kumata, Katsushi
    Shao, Tuo
    Wang, Gangqiang
    Hatori, Akiko
    Mori, Wakana
    Yu, Qingzhen
    Hu, Kuan
    Fujinaga, Masayuki
    Shao, Yihan
    Josephson, Lee
    Sun, Shaofa
    Zhang, Ming-Rong
    Liang, Steven
    TETRAHEDRON LETTERS, 2020, 61 (27)
  • [44] Synthesis and Crystal Structure of 4-{[(1E)1-(2-Hydroxy-3-methoxyphenyl)methylidene]amino}-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one
    孙玉希
    结构化学, 2007, (01) : 55 - 58
  • [45] Synthesis and crystal structure of 4-{[(1E)1-(2-hydroxy-3-methoxyphenyl)methylidene]amino}-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one
    Sun Yu-Xi
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2007, 26 (01) : 55 - 58
  • [46] Synthesis and crystal structure of a new cobalt (II) complex with 4-(p-methylphenyl)-3,5-bis(pyridin-2-yl)-1,2,4-triazole
    Zhu, DR
    Wang, ZX
    Song, J
    Li, YZ
    Lan, DY
    CHINESE JOURNAL OF INORGANIC CHEMISTRY, 2005, 21 (01) : 128 - 132
  • [47] Structure-activity relationships of the p38α MAP kinase inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl]urea (BIRB 796)
    Regan, J
    Capolino, A
    Cirillo, PF
    Gilmore, T
    Graham, AG
    Hickey, E
    Kroe, RR
    Madwed, JR
    Moriak, M
    Nelson, R
    Pargellis, CA
    Swinamer, A
    Torcellini, C
    Tsang, M
    Moss, N
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4676 - 4686
  • [48] Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure-Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)
    German, Nadezhda
    Decker, Ann M.
    Gilmour, Brian P.
    Gay, Elaine A.
    Wiley, Jenny L.
    Thomas, Brian F.
    Zhang, Yanan
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (18) : 7758 - 7769
  • [49] Synthesis and Evaluation of 3-(furo[2,3-b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3 Inhibitors and Anti-Ischemic Agents
    Ye, Qing
    Li, Qiu
    Zhou, Yubo
    Xu, Lei
    Mao, Weili
    Gao, Yuanxue
    Li, Chenhui
    Xu, Yuan
    Xu, Yazhou
    Liao, Hong
    Zhang, Luyong
    Gao, Jianrong
    Li, Jia
    Pang, Tao
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 746 - 752
  • [50] Crystal structure of 1-(4-(dimethylamino)phenyl)-2,3-bis(diphenylphosphoryl)propan-1-one, C35H33NO3P2
    Xing, Qianlu
    Ao, Junhao
    Jin, Xin
    Huang, Qiang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (04): : 791 - 793